RxDoctor Payments Data

David Wilbur

Cytopathology · Boston, MANPI 1780675215

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $5,043 of the $5,634 with a category attached, or 89.5%. Ventana Medical Systems, Inc. accounts for 99.5% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $3,294 and has fallen 99.2% since, to $28 in 2021.

$5,634in general payments, 2019–2025

Across 37 payments — averaging $152.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ventana Medical Systems, Inc.$6K
  • Boston Scientific$28
$2,781,360in research payments, 2019–2025

Across 24 payments — averaging $115,890 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ventana Medical Systems, Inc.$2.8M

What the payments were for

  • Travel & lodging$5,04390%
  • Food & beverage$59110%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Ventana Medical Systems, Inc.36$5,606
Boston Scientific1$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few cytopathology providers in Massachusettsto place this figure against a meaningful peer group, so we don't.

Other cytopathology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →